Scinovex
articleTop 1% cited

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Hepatology · 2004 · Vol. 40(6) · pp. 1387–1395
Jeffrey D. BrowningLidia S. SzczepaniakRobert L. DobbinsPamela NurembergJay D. HortonJonathan C. CohenScott M. GrundyHelen H. Hobbs

Abstract

Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), its pathogenesis and clinical significance remain poorly defined. In this study, we examined and compared the distribution of hepatic triglyceride content (HTGC) in 2,287 subjects from a multiethnic, population-based sample (32.1% white, 48.3% black, and 17.5% Hispanic) using proton magnetic resonance spectroscopy. HTGC varied over a wide range (0.0%-41.7%; median, 3.6%) in the population. Almost one third of the population had hepatic steatosis, and most subjects with hepatic steatosis had normal levels of serum alanine aminotransferase (79%). The frequency of hepatic steatosis varied significantly with ethnicity (45% in Hispanics; 33% in whites; 24% in blacks) and sex (42% in white men; 24% in white women). The higher prevalence of hepatic steatosis in Hispanics was due to the higher prevalence of obesity and insulin resistance in this ethnic group. However, the lower frequency of hepatic steatosis in blacks was not explained by ethnic differences in body mass index, insulin resistance, ethanol ingestion, or medication use. The prevalence of hepatic steatosis was greater in men than women among whites, but not in blacks or Hispanics. The ethnic differences in the frequency of hepatic steatosis in this study mirror those observed previously for NAFLD-related cirrhosis (Hispanics > whites > blacks). In conclusion, the significant ethnic and sex differences in the prevalence of hepatic steatosis documented in this study may have a profound impact on susceptibility to steatosis-related liver disease.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and TransplantationSteatosisEthnic groupMedicinePopulationDemographyLiver steatosisInternal medicineFatty liverEnvironmental healthGeography

MeSH terms

AdultBlack or African AmericanFatty LiverFemaleHispanic or LatinoHumansLiverMaleMiddle AgedMagnetic Resonance SpectroscopyProtonsTexasTriglyceridesUrban PopulationPrevalence
Citations
3,645
FWCI
42.13
field-weighted impact
References
48
Percentile
100%
vs. same field & year
Citations per year
Cited by
Ultrasonographic evaluation of fatty liver disease and cardiovascular disease in type ii diabetics
International Journal of Radiology and Diagnostic Imaging · 2020 · 0 citations
Assessment of cases of fatty liver disease using USG and CT scan
International Journal of Radiology and Diagnostic Imaging · 2021 · 0 citations
Diagnosis and Management of the Metabolic Syndrome
Circulation · 2005 · 11,687 citations
GI Epidemiology: nonalcoholic fatty liver disease
Alimentary Pharmacology & Therapeutics · 2007 · 370 citations
Metabolic Syndrome Pandemic
Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 1,543 citations
Fatty Liver
Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 798 citations
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.